Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines (Q36383797)

13 August 2017

1 reference

title

Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines (English)

1 reference

13 August 2017

Robert M Jacobson

0 references

Gregory A Poland

1 reference

13 August 2017

Inna G Ovsyannikova

1 reference

13 August 2017

Neelam Dhiman

1 reference

13 August 2017

publication date

1 February 2006

1 reference

Expert Review of Vaccines

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

33-43

1 reference

Immunologic correlates of protection induced by vaccination

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Missed opportunities for vaccination and the delivery of preventive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Variation in vaccine response in normal populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Gene expression microarrays: a 21st century tool for directed vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Immuno-informatics: Mining genomes for vaccine components

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Identification of an association between HLA class II alleles and low antibody levels after measles immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Associations between measles antibody levels and the protein structure of class II human leukocyte antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Structure of the human class I histocompatibility antigen, HLA-A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

The Biology of the Immune System

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

MHC ligands and peptide motifs: first listing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

The HLA system. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

The HLA system. Second of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

The role of B7 costimulation in T-cell immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

The role of IFN-gamma in immune responses to viral infections of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Memory in the B-cell compartment: antibody affinity maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Immunological memory to viral infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Epidemiologic methods in immunization programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Antibodies, viruses and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Immunogenicity and protective efficacy of influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Clinical effectiveness of influenza vaccination in Manitoba

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Prevention and early treatment of influenza in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Viremia, Virus Excretion, and Antibody Responses after Challenge in Volunteers with Low Levels of Antibody to Rubella Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Measles antibody: reevaluation of protective titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Inactivated poliovirus vaccine: past and present experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Pathogenesis of measles virus infection: an hypothesis for altered immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Immunogenetic mechanisms of antibody response to measles vaccine: the role of the HLA genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Cellular Immunity in Measles Vaccine Failure: Demonstration of Measles Antigen-Specific Lymphoproliferative Responses despite Limited Serum Antibody Production after Revaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Differential CD4 T cell activation in measles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Cytokine production patterns and antibody response to measles vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Twin studies of immunogenicity--determining the genetic contribution to vaccine failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

The immune response to hepatitis B vaccine in humans: inheritance patterns in families

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Response to hepatitis B vaccine: multiple HLA genes are involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Human genetics and responses to influenza vaccination: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Differential antibody responses to rubella virus infection in males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Ramifications of HLA class I polymorphism and population genetics for vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Differential HLA Gene Expression in Measles Vaccine Seropositive and Seronegative Subjects: A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Relationship of HLA-DQAI alleles and humoral antibody following measles vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

The association of class I HLA alleles and antibody levels after a single dose of measles vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

The contribution of HLA class I antigens in immune status following two doses of rubella vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Human Leukocyte Antigen Class II Alleles and Rubella‐Specific Humoral and Cell‐Mediated Immunity following Measles‐Mumps‐Rubella–II Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

The genetic basis for variation in antibody response to vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

The association between HLA class I alleles and measles vaccine-induced antibody response: evidence of a significant association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Associations between Human Leukocyte Antigen Homozygosity and Antibody Levels to Measles Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Association of HLA-DR14—DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Measles antibody seroprevalence rates among immunized Inuit, Innu and Caucasian subjects1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

Genetic regulation of immune responses to vaccines in early life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.33

21 January 2018

Identifiers

DOI

10.1586/14760584.5.1.33

1 reference

13 August 2017

1 reference